163 related articles for article (PubMed ID: 38194881)
1. Prognostic value of deep learning-derived body composition in advanced pancreatic cancer-a retrospective multicenter study.
Keyl J; Bucher A; Jungmann F; Hosch R; Ziller A; Armbruster R; Malkomes P; Reissig TM; Koitka S; Tzianopoulos I; Keyl P; Kostbade K; Albers D; Markus P; Treckmann J; Nassenstein K; Haubold J; Makowski M; Forsting M; Baba HA; Kasper S; Siveke JT; Nensa F; Schuler M; Kaissis G; Kleesiek J; Braren R
ESMO Open; 2024 Jan; 9(1):102219. PubMed ID: 38194881
[TBL] [Abstract][Full Text] [Related]
2. Deep learning-based assessment of CT markers of sarcopenia and myosteatosis for outcome assessment in patients with advanced pancreatic cancer after high-intensity focused ultrasound treatment.
Nowak S; Kloth C; Theis M; Marinova M; Attenberger UI; Sprinkart AM; Luetkens JA
Eur Radiol; 2024 Jan; 34(1):279-286. PubMed ID: 37572195
[TBL] [Abstract][Full Text] [Related]
3. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Artificial Intelligence-Driven, Computed Tomography-Based, Volumetric Assessment of the Volume and Density of Muscle in Patients With Colon Cancer.
Kim M; Lee SM; Son IT; Park T; Oh BY
Korean J Radiol; 2023 Sep; 24(9):849-859. PubMed ID: 37634640
[TBL] [Abstract][Full Text] [Related]
5. Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer.
Keyl J; Hosch R; Berger A; Ester O; Greiner T; Bogner S; Treckmann J; Ting S; Schumacher B; Albers D; Markus P; Wiesweg M; Forsting M; Nensa F; Schuler M; Kasper S; Kleesiek J
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):545-552. PubMed ID: 36544260
[TBL] [Abstract][Full Text] [Related]
6. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of initial and longitudinal changes in body composition in metastatic pancreatic cancer.
Lee MW; Jeon SK; Paik WH; Yoon JH; Joo I; Lee JM; Lee SH
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):735-745. PubMed ID: 38332658
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma.
Kim DW; Ahn H; Kim KW; Lee SS; Kim HJ; Ko Y; Park T; Lee J
Korean J Radiol; 2022 Nov; 23(11):1055-1066. PubMed ID: 36098341
[TBL] [Abstract][Full Text] [Related]
9. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
Findlay M; White K; Brown C; Bauer JD
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer.
Salinas-Miranda E; Deniffel D; Dong X; Healy GM; Khalvati F; O'Kane GM; Knox J; Bathe OF; Baracos VE; Gallinger S; Haider MA
Eur Radiol; 2021 Nov; 31(11):8662-8670. PubMed ID: 33934171
[TBL] [Abstract][Full Text] [Related]
11. Body composition parameters predict survival in pancreatic cancer-A retrospective multicenter analysis.
Damm M; Efremov L; Jalal M; Nadeem N; Dober J; Michl P; Wohlgemuth WA; Wadsley J; Hopper AD; Krug S; Rosendahl J
United European Gastroenterol J; 2023 Dec; 11(10):998-1009. PubMed ID: 37987099
[TBL] [Abstract][Full Text] [Related]
12. AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults.
Nachit M; Horsmans Y; Summers RM; Leclercq IA; Pickhardt PJ
Radiology; 2023 Jun; 307(5):e222008. PubMed ID: 37191484
[TBL] [Abstract][Full Text] [Related]
13. Effect of muscle depletion on survival in peripheral arterial occlusive disease: Quality over quantity.
Vedder IR; Levolger S; Dierckx RAJO; Zeebregts CJ; de Vries JPM; Viddeleer AR; Bokkers RPH
J Vasc Surg; 2020 Dec; 72(6):2006-2016.e1. PubMed ID: 32330596
[TBL] [Abstract][Full Text] [Related]
14. Deep Learning for Fully Automated Prediction of Overall Survival in Patients Undergoing Resection for Pancreatic Cancer: A Retrospective Multicenter Study.
Yao J; Cao K; Hou Y; Zhou J; Xia Y; Nogues I; Song Q; Jiang H; Ye X; Lu J; Jin G; Lu H; Xie C; Zhang R; Xiao J; Liu Z; Gao F; Qi Y; Li X; Zheng Y; Lu L; Shi Y; Zhang L
Ann Surg; 2023 Jul; 278(1):e68-e79. PubMed ID: 35781511
[TBL] [Abstract][Full Text] [Related]
15. Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer.
Wu CH; Chang MC; Lyadov VK; Liang PC; Chen CM; Shih TT; Chang YT
Clin Nutr; 2019 Apr; 38(2):862-869. PubMed ID: 29503056
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
Martin L; Hopkins J; Malietzis G; Jenkins JT; Sawyer MB; Brisebois R; MacLean A; Nelson G; Gramlich L; Baracos VE
Ann Surg Oncol; 2018 Sep; 25(9):2669-2680. PubMed ID: 30006691
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas.
Stretch C; Aubin JM; Mickiewicz B; Leugner D; Al-Manasra T; Tobola E; Salazar S; Sutherland FR; Ball CG; Dixon E; Vogel HJ; Damaraju S; Baracos VE; Bathe OF
PLoS One; 2018; 13(5):e0196235. PubMed ID: 29723245
[TBL] [Abstract][Full Text] [Related]
18. Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease.
Shirdel M; Andersson F; Myte R; Axelsson J; RutegÄrd M; Blomqvist L; Riklund K; van Guelpen B; Palmqvist R; Gylling B
Acta Oncol; 2020 Jul; 59(7):799-808. PubMed ID: 32228271
[No Abstract] [Full Text] [Related]
19. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.
Ninomiya G; Fujii T; Yamada S; Yabusaki N; Suzuki K; Iwata N; Kanda M; Hayashi M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2017 Mar; 39():45-51. PubMed ID: 28110029
[TBL] [Abstract][Full Text] [Related]
20. Body composition predictors of mortality on computed tomography in patients with spinal metastases undergoing surgical treatment.
Bongers MER; Groot OQ; Buckless CG; Kapoor ND; Twining PK; Schwab JH; Torriani M; Bredella MA
Spine J; 2022 Apr; 22(4):595-604. PubMed ID: 34699994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]